Paion
Germany - AachenPharmaceutical
Focus: Paion is a specialty pharmaceutical company headquartered in Aachen, Germany, focused on neurology therapeutics. Public company status indicates established market presence, though current product and pipeline data is not available.
Profile data last refreshed 20h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Paion
AI assessmentNot HiringNo open roles listed right now. Follow Paion to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Remimazolam
Procedural SedationClinical Trials (1)
NCT03329014A Trial of Intranasal Remimazolam Pharmacokinetics, Pharmacodynamics, Safety and Bioavailability
Phase 1Help build intelligence for Paion
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.